Home Newsfeeds Daré Bioscience Announces Efficacy Results From The DARE-HRT1 Phase 1 / 2 Study

Daré Bioscience Announces Efficacy Results From The DARE-HRT1 Phase 1 / 2 Study

Statistically Significant Results for Improvement in both the Vasomotor and the Vaginal Symptoms of Menopause DARE-HRT1 has the potential to be the first FDA-approved monthly intravaginal ring delivering both

byBenzinga Newsdesk

October 17, 2022

1 minute read

Statistically Significant Results for Improvement in both the Vasomotor and the Vaginal Symptoms of Menopause

DARE-HRT1 has the potential to be the first FDA-approved monthly intravaginal ring delivering both estrogen and progestogen hormone therapy

Here’s How Much You Would Have Made Owning GameStop Stock In The Last 10 Years

By Benzinga Insights

October 19, 1:06 PM

GameStop (NYSE:GME) has outperformed the market over the past 10 years by 5.69% on an annualized basis producing an average annual return of 15.71%. Currently, GameStop has a market capitalization of $7.57 billion.

GME

Why Is Management Consulting Services Company Booz Allen Hamilton Stock Jumping Today?

By Akanksha Bakshi

January 26, 12:28 PM

In Q3 2024, Booz Allen Hamilton outperformed expectations with sales of $2.57 billion and adjusted EPS at $1.41. Additionally, the firm raised its quarterly dividend to $0.51 per share and upgraded its full-year outlook, reflecting robust financial health and a positive forecast for the coming year.

BAH

Marjorie Taylor Greene’s Ageist Swipe At Biden, Trump’s Gag Order, DeSantis-Newsom TV Debate And More: This Week In Politics

By Benzinga Neuro

December 2, 10:26 AM

This week brought a flurry of political developments and controversies. FromÂ Rep. Marjorie Taylor Greene’sÂ (R-Ga.) ageist comments aboutÂ President Joe…

MSFT